-
Cancer Vaccines: Activate the Immunosoldiers – Part 2
27 Jun 2024 13:11 GMT
… is the importance of combining vaccines with checkpoint inhibitors. When … compared with other indications like mesothelioma and head and neck cancer … strategies ranging from personalized vaccines to more generalized vaccination approaches. Moving forward …
-
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
29 May 2024 13:00 GMT
… of new immunotherapeutic vaccines in oncology and prophylactic vaccines for contagious diseases … syngeneic tumor models, e.g. mesothelioma, bladder, neuroblastoma, etc. The … development of its MVdeltaC immunotherapeutic vaccine in oncology. Press contact : …
-
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
29 May 2024 11:33 GMT
… previously reported studies.
“Malignant pleural mesothelioma is typically diagnosed in advanced … permitted) alone.
About malignant mesothelioma
Malignant mesothelioma is a type of cancer … development of important medicines and vaccines. We aspire to be the …
-
Ultimovacs downsizes to funnel funds to cancer vaccine programme
17 Apr 2024 17:42 GMT
… second-line treatment in mesothelioma patients. The study … GlobalData forecasts therapeutic cancer vaccines as the weakest immuno … Arena.
Other cancer vaccines in development include Transgene … and ISA Pharmaceuticals’ cancer vaccine, ISA101b, for treating …
-
Ultimovacs Announces Topline Results from INITIUM Study Evaluating UV1 Vaccination Added to Ipilimumab and Nivolumab in Patients with Unresectable or Metastatic Malignant Melanoma
07 Mar 2024 06:25 GMT
… leader in novel immunotherapeutic cancer vaccines, today announced topline results … leader in novel immunotherapeutic cancer vaccines with broad applicability. Ultimovacs’ … for patients with malignant pleural mesothelioma. Enrollment of 118 patients …
-
Ultimovacs reports trial results of UV1 cancer vaccine
04 Mar 2024 14:13 GMT
… vaccine to second-line treatment with ipilimumab and nivolumab for pleural mesothelioma … patients.
Malignant pleural mesothelioma is an aggressive … in patients with malignant pleural mesothelioma (MPM) after first-line …
-
FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma
21 Feb 2024 21:53 GMT
… pleural mesothelioma that can’t be managed with surgery.
Therapeutic cancer vaccines … , ipilimumab, and nivolumab, in malignant mesothelioma, a hard-to-treat cancer … that didn’t receive the mesothelioma vaccine.
Investigators reported that the rates …
-
Ultimovacs bags EMA orphan drug status for cancer vaccine
20 Feb 2024 16:00 GMT
… its universal cancer vaccine UV1 for the treatment of mesothelioma.
The positive … NIPU trial evaluating the vaccine in malignant pleural mesothelioma patients, according to … – one for unresectable malignant pleural mesothelioma to improve overall survival and …
-
FDA Grants Fast Track Designation to Cancer Vaccine for Malignant Pleural Mesothelioma
05 Feb 2024 23:31 GMT
… for Patients with Malignant Mesothelioma Receiving UV1 Cancer Vaccine. Ultimovacs ASA. News … for the UV1 Cancer Vaccine for Treatment of Mesothelioma. Ultimovacs ASA. News … -for-the-uv1-cancer-vaccine-for-treatment-of-mesothelioma
4. Ultimovacs Granted …
-
Phase I Trial Improves Mesothelioma Survival More Than 200%
31 Jan 2024 23:39 GMT
… vaccine.
The trial included 10 patients with relapsed or refractory mesothelioma … Patients with relapsed or refractory mesothelioma who receive standard therapy have … relapsed/refractory WT1 positive mesothelioma,” said Sterguiou.
All patients …